Quick Answer
Neuronetics, Inc. reported Cash And Cash Equivalents At Carrying Value of $28.13 million for the year ending 2025.
- Neuronetics, Inc. showed an increase of +52.4% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
- This data is from Neuronetics, Inc.'s annual report (Form 10-K), filed with the SEC on March 17, 2026.
- XBRL data for this metric is available from 2017 to 2025 (9 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q4 2016: $17.04 million | Q2 2017: $26.23 million | Q2 2018: $14.54 million | Q3 2018: $106.76 million | Q1 2019: $96.15 million | Q2 2019: $89.64 million | Q3 2019: $82.37 million | Q1 2020: $63.65 million | Q2 2020: $54.00 million | Q3 2020: $50.72 million | Q1 2021: $121.28 million | Q2 2021: $115.78 million | Q3 2021: $99.43 million | Q1 2022: $80.84 million | Q2 2022: $70.93 million | Q3 2022: $73.70 million | Q1 2023: $55.44 million | Q2 2023: $45.91 million | Q3 2023: $35.85 million | Q1 2024: $47.73 million | Q2 2024: $42.64 million | Q3 2024: $20.87 million | Q1 2025: $20.22 million | Q2 2025: $10.97 million | Q3 2025: $27.97 million.
- Over the full 9 years of available data (2017 to 2025), Neuronetics, Inc.'s Cash And Cash Equivalents At Carrying Value has declined by 3.5%.
- Historical annual values: Fiscal year 2025: $28.13 million | Fiscal year 2024: $18.46 million | Fiscal year 2023: $59.68 million | Fiscal year 2022: $70.34 million | Fiscal year 2021: $94.14 million | Fiscal year 2020: $48.96 million | Fiscal year 2019: $75.71 million | Fiscal year 2018: $104.58 million | Fiscal year 2017: $29.15 million.
- Data sourced from SEC EDGAR public filings as of August 9, 2026.
Last verified: